Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
$317K Buy
10,224
+331
+3% +$11.2K 0.13% 95
2020
Q1
$306K Sell
9,893
-568
-5% -$19.4K 0.15% 89
2019
Q4
$389K Sell
10,461
-465
-4% -$16.6K 0.16% 91
2019
Q3
$372K Sell
10,926
-1,118
-9% -$40.7K 0.16% 90
2019
Q2
$495K Sell
12,044
-183
-1% -$7.27K 0.22% 72
2019
Q1
$493K Buy
12,227
+150
+1% +$6.01K 0.23% 71
2018
Q4
$500K Buy
12,077
+186
+2% +$7.72K 0.25% 63
2018
Q3
$497K Sell
11,891
-332
-3% -$12.8K 0.23% 69
2018
Q2
$421K Buy
12,223
+842
+7% +$28.8K 0.2% 78
2018
Q1
$383K Sell
11,381
-623
-5% -$21.4K 0.19% 75
2017
Q4
$412K Buy
+12,004
New +$409K 0.19% 80

Other funds holding PFE

TrueWealth LLC's PFE Position: Q2 2020 in Review

TrueWealth LLC increased its Pfizer (PFE) stake by 3.3% in Q2 2020, buying an estimated $11.2K and bringing the position to 10,224 shares worth $317K. The position accounts for 0.13% of the portfolio, ranked #95.

TrueWealth LLC first reported a position in PFE in Q4 2017 and has held it in 11 quarters since. The position peaked at $500K in Q4 2018. 2,442 funds tracked by Wall St. Rank hold PFE as of Q2 2020.

  • TrueWealth LLC held 10,224 shares of Pfizer worth $317K as of Q2 2020.
  • TrueWealth LLC bought 331 Pfizer shares in Q2 2020, an estimated $11.2K.
  • Pfizer made up 0.13% of TrueWealth LLC's portfolio in Q2 2020, its #95 holding.
  • TrueWealth LLC first reported a position in Pfizer in Q4 2017 and has held it in 11 quarters since.
  • TrueWealth LLC's Pfizer position peaked at $500K in Q4 2018.
  • 2,442 funds tracked by Wall St. Rank held Pfizer as of Q2 2020.

Based on TrueWealth LLC's 13F filing for Q2 2020, filed 15 Jul 2020.